The company had posted a net profit of Rs 2.76 crore for the corresponding period of the previous fiscal, it said in a statement.
Standalone net revenue from operations stood at Rs 142.95 crore as against Rs 123.59 crore for the same period a year ago.
"Consistent focus on backward integration, research and process innovation has helped company garner better foothold in the market and company's vision to invest in the new markets is showing results on the expected lines," Morepen Laboratories Chairman and MD Sushil Suri said.
Standalone net revenue from operations for the fiscal year under consideration also rose to Rs 537.03 crore as against Rs 452.46 crore for the year-ago fiscal.
Disclaimer: No Business Standard Journalist was involved in creation of this content
